Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression

BACKGROUND: Noninvasively differentiating therapy-induced pseudoprogression from recurrent disease in patients with glioblastoma is prospectively difficult due to the current lack of a biologically specific imaging metric. Ferumoxytol iron oxide nanoparticle MRI contrast characterizes innate immunit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Barajas, Ramon F, Hamilton, Bronwyn E, Schwartz, Daniel, McConnell, Heather L, Pettersson, David R, Horvath, Andrea, Szidonya, Laszlo, Varallyay, Csanad G, Firkins, Jenny, Jaboin, Jerry J, Kubicky, Charlotte D, Raslan, Ahmed M, Dogan, Aclan, Cetas, Justin S, Ciporen, Jeremy, Han, Seunggu J, Ambady, Prakash, Muldoon, Leslie L, Woltjer, Randy, Rooney, William D, Neuwelt, Edward A
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Neuroimaging
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6422439/
https://ncbi.nlm.nih.gov/pubmed/30277536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy160
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados